Next Article in Journal
Network Analysis of DSM Symptoms of Substance Use Disorders and Frequently Co-Occurring Mental Disorders in Patients with Substance Use Disorder Who Seek Treatment
Next Article in Special Issue
Vitreomacular Interface Disorders in Proliferative Diabetic Retinopathy: An Optical Coherence Tomography Study
Previous Article in Journal
Woven EndoBridge in Wide-Neck Bifurcation Aneurysms: Digital Subtraction Angiography at 3-Year Follow-Up
Previous Article in Special Issue
Association between Different Grades of Myopic Tractional Maculopathy and OCT-Based Macular Scleral Deformation
 
 

Order Article Reprints

Journal: J. Clin. Med., 2022
Volume: 11
Number: 2878

Article: Prediction of the Short-Term Therapeutic Effect of Anti-VEGF Therapy for Diabetic Macular Edema Using a Generative Adversarial Network with OCT Images
Authors: by Fabao Xu, Shaopeng Liu, Yifan Xiang, Jiaming Hong, Jiawei Wang, Zheyi Shao, Rui Zhang, Wenjuan Zhao, Xuechen Yu, Zhiwen Li, Xueying Yang, Yanshuang Geng, Chunyan Xiao, Min Wei, Weibin Zhai, Ying Zhang, Shaopeng Wang and Jianqiao Li
Link: https://www.mdpi.com/2077-0383/11/10/2878

MDPI provides article reprints in high quality with convenient shipping to destinations worldwide. The articles are printed in on premium paper with high-resolution figures. Our covers are customized to your article and designed to be complimentary to the journal. These reprints are ideal additions to your portfolio. Copy details: 135g/m2 paper, 2x stitched, full colour and glossy finish, orderable in quantities from 10 to 1000.

If you have any questions, or special requests, please write to our support team; we are happy to provide you with the information you need.

Reprint Options

If you need more than 400 copies, please contact us by e-mail (articlereprints@mdpi.com) and we will prepare an individual offer for you.

Order Cost and Details

Contact Person

Invoice Address

Notes or Comments

Validate and Place Order

The order must be prepaid after it is placed

req denotes required fields.
Back to TopTop